A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Elacytarabine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 08 Jun 2016 Last checked against United Kingdom Clinical Research Network record.
- 23 Nov 2010 New source identified and integrated (United Kingdom Clinical Research Network).
- 09 Jun 2009 Actual patient number (16) added as reported by ClinicalTrials.gov.